cytarabine has been researched along with Leukemoid Reaction in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Antary, ET; Edwards, H; Ge, Y; Gupte, A; Ravindranath, Y; Taub, JW | 1 |
| Bhatnagar, N; Greenough, A; James, B; Norton, A; O'Marcaigh, AS; Roberts, I; Tunstall, O; Vyas, P; Watts, T; Wright, M | 1 |
| Creutzig, U; de Haas, V; Flasinski, M; Klusmann, JH; Reinhardt, D; Reinhardt, K; Scheibke, K; van der Velden, VHJ; Verwer, F; von Neuhoff, C; Zimmermann, M; Zwaan, CM | 1 |
| Kaung, DT | 1 |
1 review(s) available for cytarabine and Leukemoid Reaction
| Article | Year |
|---|---|
The paradox of Myeloid Leukemia associated with Down syndrome.
Topics: Child; Cytarabine; Down Syndrome; GATA1 Transcription Factor; Humans; Leukemia, Myeloid, Acute; Leukemoid Reaction | 2022 |
1 trial(s) available for cytarabine and Leukemoid Reaction
| Article | Year |
|---|---|
Low-dose cytarabine to prevent myeloid leukemia in children with Down syndrome: TMD Prevention 2007 study.
Topics: Cytarabine; Disease Progression; Down Syndrome; Historically Controlled Study; Humans; Infant; Infant, Newborn; Leukemia, Myeloid; Leukemoid Reaction; Neoplasm, Residual; Survival Analysis | 2018 |
2 other study(ies) available for cytarabine and Leukemoid Reaction
| Article | Year |
|---|---|
Guidelines for the investigation and management of Transient Leukaemia of Down Syndrome.
Topics: Antimetabolites, Antineoplastic; Blood Cell Count; Cell Transformation, Neoplastic; Critical Illness; Cytarabine; DNA Mutational Analysis; Down Syndrome; Exchange Transfusion, Whole Blood; Female; Fetal Diseases; GATA1 Transcription Factor; Humans; Leukapheresis; Leukemoid Reaction; Liver Diseases; Mutation; Neoplasm, Residual; Pregnancy; Prenatal Diagnosis; Prognosis; Recurrence; Risk Factors | 2018 |
Leukemoid reaction in acute lymphoblastic leukemia: a response to chemotherapy.
Topics: Acute Disease; Adult; Agranulocytosis; Antineoplastic Agents; Bone Marrow; Bone Marrow Cells; Cytarabine; Humans; Leukemia, Lymphoid; Leukemoid Reaction; Male; Prednisone; Vincristine | 1973 |